Neumora Therapeutics, Inc. (NMRA)
0.3702
-0.07
(-15.34%)
USD |
NASDAQ |
Oct 13, 16:00
0.39
+0.02
(+5.35%)
Pre-Market: 08:55
Neumora Therapeutics EPS Diluted (TTM) : -1.233 for June 30, 2026
EPS Diluted (TTM) Chart
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.233 |
| March 31, 2026 | -1.327 |
| December 31, 2025 | -1.451 |
| September 30, 2025 | -1.463 |
| June 30, 2025 | -1.567 |
| March 31, 2025 | -1.610 |
| December 31, 2024 | -1.526 |
| September 30, 2024 | -1.846 |
| June 30, 2024 | -1.738 |
| March 31, 2024 | -1.623 |
| Date | Value |
|---|---|
| December 31, 2023 | -1.52 |
| September 30, 2023 | -1.021 |
| June 30, 2023 | -0.8664 |
| March 31, 2023 | -0.8126 |
| December 31, 2022 | -0.8615 |
| September 30, 2022 | -0.777 |
| June 30, 2022 | -0.5839 |
| March 31, 2022 | -0.384 |
| March 31, 2021 | -0.1007 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| BioAge Labs, Inc. | -2.387 |
| ANI Pharmaceuticals, Inc. | 4.632 |
| Corcept Therapeutics, Inc. | 0.4187 |
| Veru, Inc. | -0.6109 |
| Johnson & Johnson | 6.592 |